Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma

Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/8422

DC Field	Value	Language
dc.contributor.author	Pancevski, Goran	en_US
dc.contributor.author	Pepic, Senada	en_US
dc.contributor.author	Idoska, Sanela	en_US
dc.contributor.author	Tofoski, Gligor	en_US
dc.contributor.author	Nikolovska, Suzana	en_US
dc.date.accessioned	2020-06-11T07:33:10Z	-
dc.date.available	2020-06-11T07:33:10Z	-
dc.date.issued	2018-03-15	-
dc.identifier.issn	1857-9655	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/8422	-
dc.description.abstract	Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression.	en_US
dc.language.iso	en	en_US
dc.publisher	ID Design 2012/Scientific Foundation SPIROSKI	en_US
dc.relation.ispartof	Open Access Macedonian Journal of Medical Sciences	en_US
dc.subject	Solitary keratoacanthoma,	en_US
dc.subject	treatment,	en_US
dc.subject	Imiquimode	en_US
dc.title	Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma	en_US
dc.type	Article	en_US
dc.identifier.doi	10.3889/oamjms.2018.133	-
dc.identifier.url	https://id-press.eu/mjms/article/download/oamjms.2018.133/1945	-
dc.identifier.url	https://id-press.eu/mjms/article/download/oamjms.2018.133/1981	-
dc.identifier.volume	6	-
dc.identifier.issue	3	-
item.grantfulltext	open	-
item.fulltext	With Fulltext	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Medicine	-
crisitem.author.dept	Faculty of Dentistry	-
Appears in Collections:	Faculty of Medicine: Journal Articles

File	Description	Size	Format
Tofoski so Senada trud Topical_Imiquimod_5_as_a_Treatment_Option_in_Solit.pdf		256.7 kB	Adobe PDF	View/Open

89

checked on Jun 8, 2024

16

checked on Jun 8, 2024

Check